GH vs. CELC
GH (Guardant Health, Inc.) and CELC (Celcuity Inc.) are both stocks. Both operate in the Diagnostics & Research industry within the Healthcare sector. Over the past 5 years, GH returned 0.19%/yr vs 28.92%/yr for CELC. At a 0.24 correlation, their price movements are largely independent.
Performance
GH vs. CELC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GH achieves a 26.13% return, which is significantly higher than CELC's -9.84% return.
GH
- 1D
- -2.24%
- 1M
- 8.31%
- YTD
- 26.13%
- 6M
- 27.13%
- 1Y
- 162.17%
- 3Y*
- 53.63%
- 5Y*
- 0.19%
- 10Y*
- —
CELC
- 1D
- 2.47%
- 1M
- -34.94%
- YTD
- -9.84%
- 6M
- -11.08%
- 1Y
- 675.26%
- 3Y*
- 98.49%
- 5Y*
- 28.92%
- 10Y*
- —
GH vs. CELC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GH Guardant Health, Inc. | 26.13% | 234.34% | 12.94% | -0.55% | -72.81% | -22.39% | 64.93% | 107.87% | 35.46% |
CELC Celcuity Inc. | -9.84% | 661.96% | -10.16% | 4.00% | 6.22% | 44.00% | -13.91% | -55.65% | -16.76% |
Correlation
The correlation between GH and CELC is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Oct 4, 2018 | 0.24 |
Fundamentals
GH:
$16.91B
CELC:
$4.90B
GH:
-$3.40
CELC:
-$3.95
GH:
$1.08B
CELC:
$0.00
GH:
$701.01M
CELC:
-$41.00K
GH:
-$411.42M
CELC:
-$168.13M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GH vs. CELC — Risk / Return Rank
GH
CELC
GH vs. CELC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and Celcuity Inc. (CELC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GH | CELC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.93 | ||
| Sortino ratioReturn per unit of downside risk | -3.27 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.95 | -0.50 |
| Calmar ratioReturn relative to maximum drawdown | 4.95 | 17.14 | -12.19 |
| Martin ratioReturn relative to average drawdown | 12.27 | 56.87 | -44.60 |
Loading charts...
Drawdowns
GH vs. CELC - Drawdown Comparison
The maximum GH drawdown since its inception was -91.03%, which is greater than CELC's maximum drawdown of -85.64%. Use the drawdown chart below to compare losses from any high point for GH and CELC.
Loading charts...
Drawdown Indicators
| GH | CELC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.03% | -85.64% | -5.39% |
Max Drawdown (1Y)Largest decline over 1 year | -32.98% | -39.77% | +6.79% |
Max Drawdown (3Y)Largest decline over 3 years | -59.79% | -61.99% | +2.20% |
Max Drawdown (5Y)Largest decline over 5 years | -87.84% | -82.70% | -5.14% |
Current DrawdownCurrent decline from peak | -28.07% | -37.97% | +9.90% |
Average DrawdownAverage peak-to-trough decline | -51.50% | -44.95% | -6.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.27% | 11.96% | +1.31% |
Volatility
GH vs. CELC - Volatility Comparison
The current volatility for Guardant Health, Inc. (GH) is 13.07%, while Celcuity Inc. (CELC) has a volatility of 32.15%. This indicates that GH experiences smaller price fluctuations and is considered to be less risky than CELC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GH | CELC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.07% | 32.15% | -19.08% |
Volatility (6M)Calculated over the trailing 6-month period | 38.12% | 49.61% | -11.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.29% | 182.63% | -124.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.65% | 101.52% | -33.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.23% | 91.58% | -23.35% |
Dividends
GH vs. CELC - Dividend Comparison
Neither GH nor CELC has paid dividends to shareholders.
Financials
GH vs. CELC - Financials Comparison
This section allows you to compare key financial metrics between Guardant Health, Inc. and Celcuity Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GH and CELC have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CELC has higher volatility (32.15%) compared to GH (13.07%). In terms of maximum drawdown, GH dropped -91.03% vs CELC's -85.64%.
CELC currently has the higher Sharpe Ratio (3.74 vs 2.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GH and CELC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer